Clinvigilant Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-05-2024
- Paid Up Capital ₹ 0.10 M
as on 19-05-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -51.94%
(FY 2021)
- Profit -87.33%
(FY 2021)
- Ebitda -86.12%
(FY 2021)
- Net Worth 8.97%
(FY 2021)
- Total Assets -12.25%
(FY 2021)
About Clinvigilant Research
The Corporate was formerly known as Qscience Consultancy Private Limited. The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhumi Vyas and Ritesh Mehta serve as directors at the Company.
- CIN/LLPIN
U74995GJ2017PTC098772
- Company No.
098772
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Clinvigilant Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhumi Vyas  | Managing Director | 21-Aug-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ritesh Mehta | Director | 23-Jun-2023 | Current |
Financial Performance of Clinvigilant Research.
Clinvigilant Research Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 51.94% decrease. The company also saw a substantial fall in profitability, with a 87.33% decrease in profit. The company's net worth moved up by a moderate rise of 8.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clinvigilant Research?
Unlock access to Clinvigilant Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vriksh Wellness Private LimitedActive 2 years 5 monthsBhumi Vyas and Ritesh Mehta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Clinvigilant Research?
Unlock and access historical data on people associated with Clinvigilant Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clinvigilant Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clinvigilant Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
